| Literature DB >> 25237314 |
Naomi J Marty1, Howard J Teresinski1, Yeen Ting Hwang1, Eric A Clendening1, Satinder K Gidda1, Elwira Sliwinska2, Daiyuan Zhang3, Ján A Miernyk4, Glauber C Brito5, David W Andrews6, John M Dyer3, Robert T Mullen1.
Abstract
Tail-anchored (TA) proteins are a unique class of functionally diverse membrane proteins defined by their single C-terminal membrane-spanning domain and their ability to insert post-translationally into specific organelles with an Ncytoplasm-Corganelle interior orientation. The molecular mechanisms by which TA proteins are sorted to the proper organelles are not well-understood. Herein we present results indicating that a dibasic targeting motif (i.e., -R-R/K/H-X({X≠E})) identified previously in the C terminus of the mitochondrial isoform of the TA protein cytochrome b 5, also exists in many other A. thaliana outer mitochondrial membrane (OMM)-TA proteins. This motif is conspicuously absent, however, in all but one of the TA protein subunits of the translocon at the outer membrane of mitochondria (TOM), suggesting that these two groups of proteins utilize distinct biogenetic pathways. Consistent with this premise, we show that the TA sequences of the dibasic-containing proteins are both necessary and sufficient for targeting to mitochondria, and are interchangeable, while the TA regions of TOM proteins lacking a dibasic motif are necessary, but not sufficient for localization, and cannot be functionally exchanged. We also present results from a comprehensive mutational analysis of the dibasic motif and surrounding sequences that not only greatly expands the functional definition and context-dependent properties of this targeting signal, but also led to the identification of other novel putative OMM-TA proteins. Collectively, these results provide important insight to the complexity of the targeting pathways involved in the biogenesis of OMM-TA proteins and help define a consensus targeting motif that is utilized by at least a subset of these proteins.Entities:
Keywords: A. thaliana; dibasic motif; mitochondria; outer mitochondrial membrane; tail anchored; targeting signal
Year: 2014 PMID: 25237314 PMCID: PMC4154396 DOI: 10.3389/fpls.2014.00426
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
.
All of the proteins listed are bona fide Arabidopsis OMM proteins, based on (Duncan et al., 2011, 2013) and Klodmann et al. (2011), and are also known or predicted to possess a TA topology, based on their identification in various proteomics- and bioinformatics-based searches in Arabidopsis (Kriechbaumer et al., 2009; Pedrazzini, 2009; Dhanoa et al., 2010). The proteins are grouped by TOM proteins and all other proteins, and then listed alphabetically. See text for additional details.
bCommon nomenclature of Arabidopsis mitochondrial outer membrane TA proteins based on published literature and The Arabidopsis Information Resource (TAIR) (http://www.arabidopsis.org). Proteins indicated with an asterisk were experimentally characterized in terms of their intracellular localization and TA topology; see Figures 1, 2, and text for additional details.
cAbbreviations are: APX-5, ascorbate peroxidase isoform 5; Cb5-6, cytochrome b5 isoform 6; FIS1, fission 1; MIRO1/2, mitochondrial RHO GTPase 1 and 2; PAP2, purple acid phosphatase 2; PMD1/2, peroxisomal and mitochondrial division factor 1 and 2; TOM, translocase of the mitochondrial outer membrane (subunits 5, 6, 7, 9, and 20 and isoforms thereof); TraB, domain motif based on Enterococcus faecalis traB (An and Clewell, 1994).
dArabidopsis gene identifier (AGI) number represents the systematic designation given to each locus, gene, and its corresponding protein product(s) by TAIR.
eShown for each protein is its deduced C-terminal tail sequence, including its putative TMD (underlined), based on the TMD prediction program TOPCONS and visual inspection, and its downstream CTS. Shaded are the dibasic amino acid residues in the dibasic targeting signal motif, -R-R/K/H-X{X≠E} (Hwang et al., 2004).
Figure 1Subcellular localization of selected . BY-2 cells were transiently transformed with plasmid DNA expressing selected Myc-tagged TOM-TA proteins (A) or dibasic-motif-containing TA proteins (B) and immunostained for endogenous mitochondrial E1β or CoxII, as indicated in the panel labels. Alternatively, in (C), cells were (co-)transformed with Myc-tagged Cb5-6 and the plastid marker protein BCAT3-Cherry or the peroxisome marker protein (PTS1), which also includes the Cherry protein, or incubated with fluor-conjugated concanavalin A (ConA), serving as an ER marker stain (Tartakoff and Vassalli, 1983). Processing of cells for immunofluorescence microscopy and viewing using CLSM are as described in the “Materials and Methods.” Shown in the three panels on the right side of each row in (A) and (B) are images corresponding to a portion of the cell at higher magnification. Solid arrowheads indicate examples of the torus-shaped fluorescent structures containing the Myc-tagged TA protein delineating the spherical structures attributable to mitochondrial E1β or CoxII. The box in (C) represents the portion of the Cb5-6 and BCAT3-Cherry co-transformed cells shown at higher magnification in the panel to the right. Note also in (C) that only merged images of a Cb5-6 and PTS1 co-transformed cell or a Cb5-6-transformed cell stained with ConA are shown. Bar in (A) = 10 μm.
Figure 2Topological mapping of selected . Non-transformed (A) or transiently-transformed (B–D) BY-2 cells were formaldehyde fixed and permeabilized (as indicated above each set of images) with either Triton X-100, which perforates all cellular membranes, or, digitonin, which selectively permeabilizes the plasma membrane, then cells were processed for immuno-epifluorescence microscopy. Also indicated in each panel is the name of the immunostained transiently-expressed Myc-tagged protein or endogenous protein (i.e., E1β, CoxII or α-tubulin). Note that the presence or absence of immunofluorescence reflects whether the protein (epitope) was accessible to the applied antibodies. For instance, similar to α-tubulin in cytoplasmic microtubules (A), N-terminal Myc-tagged TOM9-2 (B) and all other known or putative TA proteins examined (C), but not endogenous E1β in the mitochondrial matrix or the control protein, Myc-TOM40 (B), were immunodetected in digitonin-permeabilized cells. Note also in (D) that Myc-TraB-HA did not colocalize with endogenous mitochondrial CoxII, indicating that the expressed protein, unlike Myc-TraB (Figure 1) is not properly targeted to mitochondria. Bar in (A,C) = 10 μm.
Figure 3Localization of various C-terminal mutant and GFP fusions of selected mitochondrial-TA proteins in BY-2 cells. Shown on the left in both (A) and (B) are schematic illustrations of various C-terminal-mutant (i.e., truncated) versions or GFP fusions of various dibasic-motif-containing TA proteins (A) or TOM-TA proteins (B) and their corresponding intracellular localization in transformed BY-2 cells. The numbers in the name of each construct denote the number of residues that were either deleted from the C terminus of the Myc-tagged wild-type TA protein or fused to the C terminus of GFP, and the numbers above each illustration correspond to the N- and C-terminal amino acid residues of the TA protein. Portions of the TA protein are represented in the illustrations by white and black boxes, the latter denoting the putative TMD; green boxes denote GFP. Cyt, cytoplasm; DNE, did not express; ER, endoplasmic reticulum; mito, mitochondria. Shown on the right in both (A) and (B) are representative immuno-epifluorescence micrographs illustrating the localization of the various constructs shown on the left. Each micrograph is labeled with the name of either the transiently-expressed Myc-tagged C-terminal mutant or GFP fusion protein, the endogenous mitochondrial marker protein, CoxII, or ConA. Boxes in the top row of (A) represent the portions of cells shown at higher magnification in the panels to the right. Arrowheads indicate examples of the torus-shaped fluorescent structures containing GFP-TraB+C24 delineating the spherical structures attributable to matrix-localized CoxII, indicating that GFP-TraB+C24 localizes to the OMM. For all other expressed proteins, only general (i.e., lower magnification) fluorescence patterns were compared with those of mitochondrial CoxII or, in the case of GFP-TOM20-4+C37, ConA-stained ER. Note also that cells transformed with Myc-TOM9-1-C61, which did not display a detectable immunofluorescence signal, were identified based on the fluorescence attributable to co-expressed β-ATPase-GFP, serving as cell transformation and mitochondrial matrix marker protein. Bar in (A) = 10 μm.
Figure 4Localization of various CTS mutants and hybrid versions of selected mitochondrial-TA proteins in BY-2 cells. Shown on the left in both (A) and (B) are schematic illustrations of various CTS mutant (truncated) or hybrid versions of selected dibasic-motif-containing TA proteins (A) and/or TOM-TA proteins (B) and their corresponding localization (or lack thereof) to mitochondria in transformed BY-2 cells. The names of the mutant and hybrid constructs represent either the specific amino acids in the CTS that were deleted from the protein or replaced with the CTS from another protein. All constructs possess an N-terminal-appended Myc-epitope tag. Shown for each construct is the corresponding C-terminal amino acid sequence, including putative TMD (underlined) and modified CTS (bolded), or lack thereof. Mitochondrial localization (indicated as “Yes” or “No”) was assessed based on colocalization (or lack thereof) of the expressed protein and the endogenous mitochondrial CoxII. Shown on the right in both (A) and (B) are representative immuno-epifluorescence micrographs illustrating the localization of the various constructs shown on the left. Each micrograph is labeled with the name of either the expressed Myc-tagged CTS mutant or hybrid protein or endogenous CoxII. Bar in (A) = 10 μm.
Figure 5Localization of various CTS mutant versions of the mitochondrial-TA protein TraB in BY-2 cells. Shown on the left are schematic illustrations of wild-type and various CTS mutant versions of TraB and their corresponding localization (or lack thereof) to mitochondria in transformed BY-2 cells. The names of the mutant constructs represent the specific amino acids in their modified CTSs. All constructs possess an N-terminal-appended Myc-epitope tag. Shown for each construct is the corresponding C-terminal amino acid sequence, including putative TMD (underlined) and modified (or wild-type) CTS; additional amino acid residues inserted into the TraB CTS (i.e., threonines) are bolded. Mitochondrial localization (indicated as “Yes” or “No”) was assessed based on colocalization (or lack thereof) of the expressed protein and endogenous mitochondrial CoxII. Shown on the right in both are representative immuno-epifluorescence micrographs illustrating the localization of the various constructs shown on the left. Each micrograph is labeled with the name of the expressed Myc-tagged wild-type TraB or CTS mutant version of TraB, or endogenous CoxII. Bar = 10 μm.
Figure 6Localization of various CTS mutant versions of the mitochondrial-TA hybrid protein TraBΔCb5-6. Shown on the left are schematic illustrations of wild-type and various CTS mutant versions of the hybrid protein TraBΔCb5-6CTS and their corresponding localization (or lack thereof) to mitochondria in transformed BY-2 cells. The names of the mutant constructs represent the specific amino acids in their CTSs. All constructs possess an N-terminal-appended Myc-epitope tag. Shown for each construct is the corresponding C-terminal amino acid sequence, including putative TraB TMD (underlined) and modified (or wild-type) Cb5-6 CTS; modified or additional amino acid residues inserted into the Cb5-6 CTS are bolded. Mitochondrial localization (indicated as “Yes” or “No”) was assessed based on colocalization (or lack thereof) of the expressed protein and endogenous mitochondrial CoxII. Shown on the right in both are representative immuno-epifluorescence micrographs illustrating the localization of the various constructs shown on the left. Each micrograph is labeled with the name of the expressed Myc-tagged TraBΔCb5-6CTS or CTS mutant version of TraBΔCb5-6CTS, or endogenous CoxII. Bar = 10 μm.
Figure 7Localization of various CTS mutant versions of mitochondrial-TA proteins in BY-2 cells. Shown on the left are schematic illustrations of wild-type and/or various CTS mutant versions of TraB, Cb5-6, or PMD2 and their corresponding localization (or lack thereof) to mitochondria in transformed BY-2 cells. The names of the mutants represent the specific amino acids in their modified CTSs. All constructs also possess an N-terminal-appended Myc-epitope tag. Shown for each construct is the corresponding C-terminal amino acid sequence, including putative TMD (underlined) and modified (or wild-type) CTS from TraB, Cb5-6 and PMD2; modified amino acid residues in the protein's CTS are bolded. Mitochondrial localization (indicated as “Yes” or “No”) was assessed based on colocalization (or lack thereof) of the expressed protein and endogenous mitochondrial CoxII. Shown on the right in both are representative immuno-epifluorescence micrographs illustrating the localization of the various constructs shown on the left. Each micrograph is labeled with the name of the expressed Myc-tagged wild-type and/or CTS mutant version of TraB, Cb5-6, or PMD2 or endogenous CoxII. Bar = 10 μm.
Candidate .
All of the proteins listed are known or predicted to possess a TA orientation (Kriechbaumer et al., 2009; Pedrazzini, 2009; Dhanoa et al., 2010) and also contain a C-terminal mitochondrial dibasic targeting signal motif according to the results of the mutational analysis of selected TA proteins presented this study (see Figures 5–7). See text, including Materials and Methods, for additional details.
bAGI number represents the systematic designation given to each locus, gene, and its corresponding protein product(s) in TAIR. Proteins are listed in ascending order based on their AGI number.
cCommon nomenclature of Arabidopsis TA proteins based on published literature and TAIR. Proteins indicated with an asterisk are also listed in Table 1; proteins indicated with two asterisks were experimentally characterized in terms of their intracellular localization and, for At1g55450, also TA orientation, membrane integration, and C-terminal-tail-dependent targeting; see Figure 8 and text for additional details.
dShown for each protein is its deduced C-terminal tail sequence, including its putative TMD (underlined), based on TOPCONS and visual inspection, and its downstream CTS. Shaded are the dibasic amino acid residues within the mitochondrial dibasic targeting signal motif (i.e., -R/K/H-X{0,1≠E}-R/K/H{≠-H-H- or -H-X-H-}-X{0,1≠E}X{0,3}{CTS=3,8}) found in the CTS of all the proteins shown.
eShown for each protein is its intracellular localization(s) based on published proteomics and/or GFP localization results presented at SUBA3 (The SUBcellular localization database for Arabidopsis proteins) (Tanz et al., 2013). Abbreviations: ER, endoplasmic reticulum; Mito, mitochondria; Perox, peroxisome; PM, plasma membrane; Vac, vacuole.
fShown for each protein is “cellular component” ontology, i.e., where a gene product is located in is a subcompartment of a particular cellular component, based on the AmiGO search tool at the Gene Ontology database (http://www.geneontology.org) (Ashburner et al., 2000). Abbreviations: Cyt, cytosol; TGN, trans-Golgi network; see also above (footnote e).
Figure 8Localization, topology, membrane insertion, and C-terminal targeting-signal analysis of a novel OMM-TA protein, At1g55450. (A) Representative CLSM micrographs illustrating the localization of N-terminal Myc-tagged At1g55450 or MIRO3 to the OMM in BY-2 cells. Cells were processed for immunofluoescence CLSM as in Figure 1. Shown in the three panels on the right are images corresponding to a portion of the cell at higher magnification. Solid arrowheads indicate examples of the torus-shaped fluorescent structures containing the transiently-expressed protein delineating the spherical structures attributable to endogenous CoxII. (B) Topological mapping of Myc-At1g55450 in differential-permeabilized BY-2 cells. Cells transiently-transformed with N-terminal Myc-tagged At1g55450 were formaldehyde fixed and permeabilized with either Triton X-100 or digitonin, and then cells were processed for immuno-epifluorescence microscopy, as described in Figure 2. (C) Insertion of At1g55450 into mitochondrial membranes in vitro. Isolated pea mitochondria were incubated with in vitro synthesized Myc-At1g55450 (lanes 1 and 2) or, for comparative purposes, Myc-TraB (lanes 3 and 4), and then resuspended (+) or not (−) in alkaline Na2CO3. Equivalent amounts of each alkaline Na2CO3- or mock-extracted sample were then subjected to SDS-PAGE and phosphoimaging. (D) Representative immuno-epifluorescence micrographs illustrating the localization of a C-terminal mutant or GFP fusion of At1g55450 in BY-2 cells. Each micrograph is labeled with the name of either the transiently-expressed Myc-tagged C-terminal mutant or GFP fusion protein or endogenous CoxII. The name of each construct includes the number of amino acid residues that were either deleted from the C terminus of Myc-tagged At1g55450 (−C26) or fused to the C terminus of GFP (+C26). (E) Representative CLSM micrographs illustrating the localization of the Cherry-At1g55450 fusion protein to mitochondria in living transgenic A. thaliana seedlings co-expressing the mitochondrial marker protein mito-GFP. Labels above the panels indicate the name of the co-expressed protein and labels in panels on the left indicate the seedling tissue type. Note in the top row that not all root cells expressed the Cherry-At1g55450 fusion protein. Bars in (A and B) and (D and E) = 10 μm.